Considering a switch from IVIg to SCIg for primary immunodeficiency? Explore differences in responsibility, side effects, ...

Alyglo is manufactured using cation exchange chromatography, which reduces coagulation factor XIa to undetectable levels. Alyglo ™ (immune globulin intravenous, human-stwk) 10% liquid is now available ...

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/z9w4l8/primary_immune) has announced the addition of the "Primary Immune ...

When you live with primary immunodeficiency (PI), daily routines, such as going to school, working, and seeing friends and family, can turn into a potential health risk. Because PI is rare and you may ...

Last month, Takeda revealed it was building a new manufacturing facility in Japan which would increase the company’s capacity for plasma production nearly fivefold in that country. Three weeks later, ...

The FDA has accepted Pharming Group’s supplemental new drug application for leniolisib in treating activated phosphoinositide 3-kinase delta syndrome, or APDS, in children aged 4 to 11 years, ...

Children with certain immunodeficiency diseases carry mutations in genes that regulate the body's immune system against viral infections and they have a higher mortality rate due to COVID-19. This is ...

Please provide your email address to receive an email when new articles are posted on . “In our outpatient clinic, a lot of our primary immunodeficiency (PID) patients complain of fatigue, not being ...

Primary immunodeficiency diseases (PIDDs)—now more commonly called inborn errors of immunity (IEI)—are rare genetic disorders that cause at least one part of the immune system to malfunction. Though ...

Hypogammaglobulinemia is a condition when a person has very low levels of antibodies called immunoglobulins. Someone with this condition may experience frequent infections, such as pneumonia or ...

BROOKLYN, NY, USA, February 29, 2024 /EINPresswire / -- Market Overview: The primary immune deficiency market reached a value of US$ 5.7 Billion in 2023 and expected to reach US$ 9.4 Billion by 2034, ...